Literature DB >> 5785133

Studies on the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine.

S Bygdeman, O Johnsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5785133     DOI: 10.1111/j.1748-1716.1969.tb04364.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


× No keyword cloud information.
  13 in total

1.  Catecholamine uptake, accumulation, and release in acute porphyria.

Authors:  M F Beal; N O Atuk; T C Westfall; S M Turner
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Effect of catecholamines on ADP aggregation of rat platelets in vivo.

Authors:  M G Doni; R Aragno
Journal:  Experientia       Date:  1977-10-15

3.  Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets.

Authors:  P Lasch; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

4.  [3H] Dihydroergonine binding to alpha-adrenergic receptors in human platelets.

Authors:  K H Jakobs; R Rauschek
Journal:  Klin Wochenschr       Date:  1978

5.  Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.

Authors:  K D Newman; L T Williams; N H Bishopric; R J Lefkowitz
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Lowering of kininogen in rat blood by adrenaline and its inhibition by sympatholytic agents, heparin and aspirin.

Authors:  A Castania; A M Rothschild
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

7.  Inhibition of adrenaline-induced platelet aggregation by the alpha-adrenoceptor blocking drug benextramine.

Authors:  B Belleau; B G Benfey; C Melchiorre; M Montambault
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

8.  Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

Authors:  M A Pfeifer; K Ward; T Malpass; J Stratton; J Halter; M Evans; H Beiter; L A Harker; D Porte
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Inhibition of adrenaline-induced platelet aggregation by the orally administered alpha-adrenergic receptor blocker phentolamine (Regitine).

Authors:  B Pfister; P R Imhof
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

10.  Effects of adrenoceptor blockade on plasma catecholamine levels during adrenaline infusion.

Authors:  B J Britton; M H Irving; W G Wood
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.